###begin article-title 0
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
Cia5d regulates a new fibroblast-like synoviocyte invasion-associated gene expression signature
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Introduction
###end title 2
###begin p 3
###xml 4 13 4 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 311 320 311 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 951 957 951 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 269 273 <span type="species:ncbi:10116">rats</span>
The in vitro invasive properties of rheumatoid arthritis (RA) fibroblast-like synoviocytes (FLSs) have been shown to correlate with disease severity and radiographic damage. We recently determined that FLSs obtained from pristane-induced arthritis (PIA)-susceptible DA rats are also highly invasive in the same in vitro assay through Matrigel. The transfer of alleles derived from the arthritis-resistant F344 strain at the arthritis severity locus Cia5d (RNO10), as in DA.F344(Cia5d) congenics, was enough to significantly and specifically reduce the invasive properties of FLSs. This genetically controlled difference in FLS invasion involves increased production of soluble membrane-type 1 matrix metalloproteinase (MMP) by DA, and is dependent on increased activation of MMP-2. In the present study we aimed to characterize the pattern of gene expression that correlates with differences in invasion in order to identify pathways regulated by the Cia5d locus.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 371 372 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 59 63 <span type="species:ncbi:10116">rats</span>
Synovial tissues were collected from DA and DA.F344(Cia5d) rats 21 days after the induction of PIA. Tissues were digested and FLSs isolated. After a minimum of four passages, FLSs were plated on Matrigel-covered dishes at similar densities, followed by RNA extraction. Illumina RatRef-12 expression BeadChip arrays were used. Expression data were normalized, followed by t-test, logistic regression, and cluster analysis. Real-time PCR was used to validate the microarray data.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 194 196 194 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 409 415 409 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 426 430 426 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras</italic>
###xml 675 681 675 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
Out of the 22,523 RefSeq gene probes present in the array, 7,665 genes were expressed by the FLSs. The expression of 66 genes was significantly different between the DA and DA.F344(Cia5d) FLSs (P < 0.01). Nineteen of the 66 differentially expressed genes (28.7%) are involved in the regulation of cell cycle progression or cancer-associated phenotypes, such as invasion and contact inhibition. These included Cxcl10, Vil2 and Nras, three genes that are upregulated in DA and known to regulate MMP-2 expression and activation. Nine of the 66 genes (13.6%) are involved in the regulation of estrogen receptor signaling or transcription. Five candidate genes located within the Cia5d interval were also differentially expressed.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 98 103 98 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d</italic>
We have identified a novel FLS invasion associated gene expression signature that is regulated by Cia5d. Many of the genes found to be differentially expressed were previously implicated in cancer cell phenotypes, including invasion. This suggests a parallel in the behavior of arthritis FLSs and cancer cells, and identifies novel pathways and genes for therapeutic intervention and prognostication.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 469 470 469 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 471 472 471 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Rheumatoid arthritis (RA) is a common chronic autoimmune disease that affects approximately 1% of the population [1]. It is a complex trait, in which genetic and environmental factors mediate disease susceptibility and severity [1]. Basic joint pathology in RA is characterized by pronounced synovial hyperplasia, also called 'pannus', which produces several proinflammatory cytokines and proteases and, like a malignant tumor, invades and destroys cartilage and bone [2-4].
###end p 11
###begin p 12
###xml 143 144 143 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 243 244 243 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 245 246 245 246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 491 492 491 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 521 523 521 523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 632 633 632 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 634 635 634 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
The formation of the synovial pannus is regulated by complex interactions between synovial resident cells and infiltrating inflammatory cells [5,6], and their production of paracrine and autocrine factors such as cytokines and growth factors [7-9], nuclear factor-kB activation [10], and angiogenesis [11]. The fibroblast-like synoviocyte (FLS) is a key player in this process, and its numbers are markedly increased in the hyperplastic synovial pannus of RA and rodent models of arthritis [4]. RA FLSs invade cartilage [12] and produce increased amounts of several proteolytic enzymes that further contribute to joint destruction [2,3]. The invasive properties of RA FLSs have also been associated with radiographic damage in RA, a parameter of disease severity, which emphasizes their direct clinical relevance [13].
###end p 12
###begin p 13
###xml 30 36 30 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 322 328 322 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 431 433 431 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 470 476 470 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 98 102 <span type="species:ncbi:10116">rats</span>
###xml 287 291 <span type="species:ncbi:10116">rats</span>
We have previously identified Cia5d as an arthritis severity locus and showed that DA.F344(Cia5d) rats congenic for this interval developed significantly milder arthritis, with nearly no pannus formation and neither bone nor cartilage destruction, as compared with highly susceptible DA rats [14]. We also determined that Cia5d regulates the invasive properties of FLSs, thus providing an explanation for its role in joint damage [15]. The arthritis gene located within Cia5d controls the FLS production of soluble membrane-type 1 (MT1)-matrix metalloproteinase (MMP) and activation of MMP-2 [15]. This was the first time that FLS phenotypes were found to be genetically regulated.
###end p 13
###begin p 14
###xml 366 370 <span type="species:ncbi:10116">rats</span>
In the present study we took advantage of this genetically regulated FLS invasive phenotype and compared highly invasive with minimally invasive cells' gene expression signatures using microarrays. The study of more than 22,000 genes identified a gene expression signature related to invasion that is differentially regulated between FLSs from DA and DA.F344(Cia5d) rats. The novel FLS invasion pathways described here resemble those described in cancer cell lines and have the potential to become novel targets for therapeutic intervention.
###end p 14
###begin title 15
Materials and methods
###end title 15
###begin title 16
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats
###end title 16
###begin p 17
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 48 52 <span type="species:ncbi:10116">rats</span>
###xml 413 416 <span type="species:ncbi:10116">rat</span>
###xml 587 591 <span type="species:ncbi:10116">rats</span>
DA (DA/BklArbNsi, arthritis-susceptible) inbred rats (originally from Bentin & Kingman, CA, USA) were maintained at the Arthritis and Rheumatism Branch (Arb; National Institutes of Health) and then transferred to the Feinstein Institute (previously named North Shore-LIJ Institute; Nsi). The genotype-guided breeding of DA.F344(Cia5d) was previously described in detail [14]. Briefly, a 37.2 megabase interval on rat chromosome 10 was transferred from F344 into the DA background over 10 backcrosses followed by at least five intercrosses (Figure 1). The experiments were conducted with rats homozygous at the congenic interval. All experiments involving animals were reviewed and approved by the Feinstein Institute for Medical Research Institutional Animal Care and Use Committee. Animals were housed in a pathogen free environment, on 12-hour light and dark cycles, with free access to food and water.
###end p 17
###begin p 18
###xml 7 13 7 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
Map of Cia5d congenic interval. Markers used in the breeding of DA.F344(Cia5d) congenics and their positions on chromosome 10. Numbers represent the position in the chromosomes. Mb, megabases.
###end p 18
###begin title 19
Induction of PIA and arthritis scoring
###end title 19
###begin p 20
###xml 126 128 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 129 131 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 260 262 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 263 265 262 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats aged 8 to 12 weeks received 150 mul of pristane by intradermal injection divided into two sites at the base of the tail [14,16]. The animals were scored on days 14, 18 and 21 after pristane induction using a previously described arthritis scoring system [17,18]. On day 21 after injection, the animals were killed and synovial tissue was collected from the ankles for FLS isolation.
###end p 20
###begin title 21
Isolation and culture of primary FLS
###end title 21
###begin p 22
###xml 449 455 <span type="species:ncbi:9913">bovine</span>
FLSs were isolated by enzymatic digestion of the synovial tissue. Briefly, tissues were minced and incubated with a solution containing DNase 0.15 mg/ml, hyaluronidase type I-S 0.15 mg/ml, and collagenase type IA 1 mg/ml (Sigma-Aldrich, St. Louis, MO, USA) in Dulbecco's modified Eagle's medium (DMEM; Gibco, Invitrogen Corporation, Carlsbad, CA, USA) for 1 hour at 37degreesC. Cells were washed and re-suspended in DMEM supplemented with 10% fetal bovine serum (Gibco), glutamine 30 mg/ml, amphotericin B 250 mug/ml (Sigma), and gentamicin 10 mg/ml (Gibco). After overnight culture, nonadherent cells were removed and adherent cells were cultured. All experiments were performed with cells after passage four (95% FLS purity).
###end p 22
###begin title 23
Flow-cytometric characterization of FLSs
###end title 23
###begin p 24
###xml 118 124 <span type="species:ncbi:9913">bovine</span>
Freshly trypsinized FLSs (105) were re-suspended in phosphate-buffered saline with 0.02% azide (Sigma-Aldrich) and 1% bovine serum albumin (P Biomedicals, Aurora, OH, USA), and incubated with 1 mug anti-CD32 (Pharmingen, San Diego, CA, USA) to block Fcgamma II receptors. Cells were stained with saturating concentrations of CD90 (OX-7; PerCP, Pharmingen) or isotype control. Stained cells were fixed with 1% paraformaldehyde in phosphate-buffered saline and analyzed by flow cytometry in a FACSCalibur (Becton Dickinson, Franklin Lakes, NJ, USA), using the BD Cell-Questtrade mark Pro version 4.0.1 software (Becton Dickinson).
###end p 24
###begin title 25
FLS culture on Matrigel
###end title 25
###begin p 26
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 507 509 507 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 866 868 866 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 1009 1015 <span type="species:ncbi:9913">bovine</span>
We previously studied the invasive properties of FLSs through a collagen matrix (Matrigel). Cell interactions with the extracellular matrix are known to influence the expression of several genes, including activation of MMP-2 [19], which is a key mediator of the FLS invasive phenotype. Therefore, in order to study the gene expression signature of highly invasive and minimally invasive FLSs, cells were cultured under the same conditions as used in the invasion studies. Specifically, 100% confluent 75 cm2 FLS culture flasks were trypsinized (trypsin 0.25% with EDTA 0.1%). The rates of cellular proliferation differed among cell lines, and we previously showed that FLS proliferation does not correlate with the FLS invasive behavior. In order to have similar cell confluence at the time of FLS harvesting for RNA extraction, 10% to 50% of the high-density 75 cm2 cell culture flasks (depending on the cell line) were plated in Matrigel-coated 10 cm culture dishes (Becton Dickinson) with DMEM, 10% fetal bovine serum, antibiotics, and glutamine. Cell cultures were maintained at 37degreesC with 5% carbon dioxide for 24 hours. After 24 hours, FLSs were harvested using a cell scraper (Corning, Acton, MA, USA) followed by digestion of the Matrigel with 10 ml collagenase D 1 mg/ml (Roche Applied Science, Indianapolis, IN, USA) at 37degreesC for 10 minutes. FLSs were then collected by centrifugation, washed twice with ice-cold phosphate-buffered saline. Cell pellets were re-suspended in RLT lysis buffer (RNeasy Mini Kit; Qiagen, Valencia, CA, USA) with 1% (vol/vol) beta-mercaptoethanol (Sigma). Cell-lysis buffer suspension was vortexed, frozen in liquid nitrogen and stored at -80degreesC until RNA extraction.
###end p 26
###begin title 27
RNA extraction and quality assessment
###end title 27
###begin p 28
Cells in RLT buffer were disrupted using QIAshredder spin columns (Qiagen), and total RNA was extracted using the RNeasy Mini Kit (Qiagen), in accordance with the manufacturer's instructions. Samples were digested with DNase (Qiagen) and eluted with 30 mul RNase-free water. RNAs were quantified and assessed for purity using a NanoDrop spectrophotometer (Rockland, DE, USA). RNA integrity was verified with a BioAnalyzer 2100 (Agilent, Palo Alto, CA, USA).
###end p 28
###begin title 29
RNA preparation and microarray experiments
###end title 29
###begin p 30
###xml 373 382 373 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 79 82 <span type="species:ncbi:10116">rat</span>
The RatRef-12 Expression BeadChip contains 22,524 probes for a total of 22,228 rat genes selected primarily from the NCBI RefSeq database (Release 16; Illumina, San Diego, CA, USA), and was used in accordance with the manufacturer's instructions. All reagents have been optimized for use with Illumina's Whole-Genome Expression platform. Total RNA 200 ng was used for cRNA in vitro transcription and labeling with the TotalPreptrade mark RNA Labeling Kit using Biotinylated-UTP (Ambion, Austin, TX, USA). Hybridization is carried out in Illumina Intellihyb chambers at 58degreesC for 18.5 hours, which is followed by washing and staining, in accordance with the Illumina Hybridization System Manual. The signal was developed by staining with Cy3-streptavidin. The BeadChip was scanned on a high resolution Illumina BeadArray reader, using a two-channel, 0.8 mum resolution confocal laser scanner.
###end p 30
###begin title 31
Data extraction and normalization
###end title 31
###begin p 32
###xml 270 271 270 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
The Illumina BeadStudio software (Version 2.0) was used to extract and normalize the expression data (fluorescence intensities) for the mean intensity of all 12 arrays. Genes expressed in all 12 arrays were selected for analyses. Normalized data were analyzed using the t-test and logistic regression.
###end p 32
###begin title 33
Statistics and analyses
###end title 33
###begin p 34
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 103 105 103 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 299 301 299 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 729 731 727 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 800 802 796 798 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 841 843 837 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 877 879 873 875 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 894 895 890 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
The t-test was used to compare means of the log-transformed and non-log-transformed data. Genes with a P value under 0.01 between DA and DA.F344(Cia5d) were considered significant and included in additional analysis. The logistic regression model fitting was carried out as previously described [20,21] using the filtered gene list. The statistical significance of a logistic regression result was obtained by comparing the deviance with the 'null deviance'. This null deviance is the (-2)log-likelihood of a random model in which the probability for a sample to belong to a group (for example, DA) is equal to the proportion of DA samples in the dataset. The difference between the deviance and the null deviance follows the chi2 distribution with one degree of freedom by chance alone, and this chi2 distribution was used to determine the P value. The R statistical package [22] was used for t-test and logistic regression analyses.
###end p 34
###begin p 35
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 44 51 <span type="species:ncbi:28980">Redwood</span>
The Ingenuity IPA 5.5.1 program (Ingenuity, Redwood City, CA, USA) and PubMed and GEO (Gene Expression Omnibus) searches were used for pathways detection. CLUSTER [23] and TREEVIEW [24] were used for cluster analysis and generation of a heat map.
###end p 35
###begin title 36
Quantitative real-time PCR
###end title 36
###begin p 37
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1238 1239 1206 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1321 1335 1289 1295 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;Ct </sup>
###xml 1336 1338 1296 1298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
The same RNA used for the microarray experiments was also used for the quantitative real-time PCR confirmation experiments. Total RNA 200 ng from each sample was used for cDNA synthesis using the Superscript III kit (Invitrogen). Primers and probe sequences were designed to target the same exon as used in the Illumina RatRef-12 Expression BeadChip. We used Exiqon (Woburn, MA, USA) and Taqman (ABI, Applied Biosystems, Foster City, CA) probes (Table 1). GAPDH was used as endogenous control. Probes were labeled with FAM at the 5' end and TAMRA at 3' end and used at a final concentration of 100 nmol/l. Primers were used at 200 nmol/l concentration with Eurogentec quantitative real-time PCR mastermix (Eurogentec, San Diego, CA, USA). The ABI 7700 quantitative real-time PCR thermocycler was used at 48degreesC for 30 minutes, 95degreesC for 10 minutes, and 45 cycles of 95degreesC for 0.15 minutes and 60degreesC for 1 minute. Samples were run in duplicates and the means used for analysis. Data were analyzed using Sequence Detection System software version 1.9.1 (ABI). Results were obtained as Ct (threshold cycle) values. Relative expression of all the genes was adjusted for GAPDH in each sample (DeltaCt), and DeltaCt used for t-test analysis. Quantitative real-time PCR fold differences were calculated with 2-DeltaDeltaCt [25].
###end p 37
###begin p 38
Genes studied with QPCR for confirmatory studies, primers and probe sequences
###end p 38
###begin p 39
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 15 16 15 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
aTaqman probe. bSame region used in the Illumina microarray.
###end p 39
###begin title 40
Results
###end title 40
###begin title 41
Characterization of the FLS cell lines used
###end title 41
###begin p 42
###xml 142 148 142 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 491 493 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 787 789 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
In previous studies we determined that DA FLSs were highly invasive, and that alleles derived from the arthritis-resistant strain F344 at the Cia5d interval, as in DA.F344(Cia5d) congenics (Figure 1), specifically reduced the invasive properties of FLSs. Additionally, FLSs from DA and DA.F344(Cia5d) strains expressed similar mRNA levels of transforming growth factor-beta, tumor necrosis factor-alpha, IL-1beta and IL-6, as well as MMP-1, MMP-2, MMP-3, MMP-9, MMP-13, MT1-MMP and MT2-MMP [15]. Both strains had similar collagenase and MMP-3 activity, but levels of soluble MT1-MMP and active MMP-2 were increased in DA. MMP-2 inhibition reduced DA FLS invasion to levels similar to those of DA.F344(Cia5d). Cytoskeleton characteristics were also similar in DA and DA.F344(Cia5d) FLSs [15].
###end p 42
###begin p 43
###xml 68 70 68 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 131 133 131 133 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 386 387 380 381 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 213 217 <span type="species:ncbi:10116">rats</span>
In the present study FLSs were stained with CD90, a marker for FLS [26], and analyzed by flow cytometry. Comparable numbers of CD90+ cells were detected both in five different DA and five different DA.F344(Cia5d) rats (percentage of CD90+ cells [mean +/- standard deviation]: DA 95.46 +/- 8.9 and DA.F344 [Cia5d] 96.51 +/- 5.9), demonstrating that the cell lines were homogeneously CD90+.
###end p 43
###begin title 44
Genes expressed by FLSs and filtering criteria
###end title 44
###begin p 45
A total of 7,665 genes out of 22,228 genes represented in the Illumina RatRef-12 BeadChip were expressed by both DA and DA.F344(Cia5d) FLSs. Log transformation did not significantly affect the list of differentially expressed genes, and therefore results are shown from analyses done with non-log-transformed data.
###end p 45
###begin title 46
Genes differentially expressed between DA and DA.F344(Cia5d) FLSs
###end title 46
###begin p 47
###xml 22 24 22 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 55 56 55 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 237 243 237 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 349 350 349 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 463 464 463 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 522 528 522 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 957 958 957 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Sixty-six genes had a P value under 0.01 (Tables 2 and 3) and were used for fold change calculations and pathway detection analyses. Thirty-six genes were expressed in increased levels by DA FLSs, and the presence of F344 alleles at the Cia5d interval, as in DA.F344(Cia5d) congenics FLSs, was enough to reduce their expression significantly (Table 2). Thirty genes were expressed in reduced levels in DA and significantly increased in DA.F344(Cia5d) FLSs (Table 3). These observations demonstrate that alleles within the Cia5d interval, the only genetic difference between DA and DA.F344(Cia5d), are directly or indirectly involved in the regulation of the expression of several genes, and the difference in gene expression correlates with the difference in invasive properties of FLSs. Furthermore, cluster analysis separated DA FLSs from DA.F344(Cia5d) FLSs, demonstrating that the two strains could be reliably differentiated by gene expression (Figure 2).
###end p 47
###begin p 48
Genes with reduced expression in synovial fibroblasts from DA.F344 (Cia5d) compared with highly invasive DA, including those associated with cancer-phenotypes and estrogen signaling
###end p 48
###begin p 49
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
###xml 347 348 347 348 <sup xmlns:xlink="http://www.w3.org/1999/xlink">f</sup>
aEstrogen; ER, estrogen-induced, or estrogen-receptor signaling or degradation are marked in bold. bt test. cOrder (logistic regression) in the list of 66 genes differentially expressed between DA and DA.F344(Cia5d). dCancer and invasion associated genes are in italics. eDifferentially expressed in prostate, breast, colon or pharyngeal cancers. fKnown to induce transcription or activation of gelatinases.
###end p 49
###begin p 50
Genes with increased expression in synovial fibroblasts from DA.F344 (Cia5d) compared with DA
###end p 50
###begin p 51
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
###xml 99 100 99 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">b</sup>
###xml 108 109 108 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">c</sup>
###xml 217 218 217 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink">d</sup>
###xml 271 272 271 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink">e</sup>
aEstrogen; ER, estrogen-induced, or estrogen-receptor signaling or degradation are marked in bold. bt test. cOrder (logistic regression) in the list of 66 genes differentially expressed between DA and DA.F344(Cia5d). dCancer and invasion associated genes are in italics. eIncreased expression in invading breast cancers.
###end p 51
###begin p 52
Cluster analysis and heat map of 66 differentially expressed genes. DA and DA.F344(Cia5d) samples are clustered on columns and genes on rows. Bars on the left side of the figure identify the three clusters of genes with reduced expression (green) and the three clusters of genes with increased expression (red) in DA compared with DA.F344(Cia5d).
###end p 52
###begin title 53
Genes upregulated in the highly invasive DA FLSs and downregulated in DA.F344(Cia5d) include cancer-associated and invasion regulatory genes
###end title 53
###begin p 54
###xml 108 109 108 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 277 283 277 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 294 300 294 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmbp </italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 375 380 375 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpv2</italic>
###xml 392 398 392 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Smc1L1</italic>
###xml 447 453 447 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 455 462 455 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ranbp6 </italic>
###xml 466 473 466 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hnrpul2</italic>
###xml 679 684 679 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rpa2 </italic>
###xml 688 692 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rpa3</italic>
###xml 710 716 710 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras</italic>
###xml 734 739 734 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmbp</italic>
###xml 758 763 758 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 767 773 767 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brms1l</italic>
###xml 796 797 796 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 809 816 809 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 926 927 926 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
Cluster analysis identified three main clusters among the genes expressed in increased levels in DA (Figure 2). One of the three clusters contained eight genes, three of which have been implicated in cancer and cancer-related cellular phenotypes such as invasion, and included Cxcl10, Vil2 and Dnmbp (Figure 3). The other genes in this cluster are involved in ion transport (Trpv2), mitosis (Smc1L1), or have incompletely characterized functions (Trim16, Ranbp6 and Hnrpul2). In total, 12 out of the 36 genes (33.3%) expressed in increased levels by DA FLSs and downregulated in DA.F344(Cia5d) are known to regulate cancer-associated processes, including cell cycle progression (Rpa2 and Rpa3), cell invasion (Cxcl10, Vil2, Nras, and Dnmbp), and metastasis (Vil2 and Brms1l), respectively (Table 2). In fact, Cxcl10 was the second best discriminator between DA and DA.F344(Cia5d) cell lines, as per logistic regression (Table 2).
###end p 54
###begin p 55
###xml 179 192 179 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10, Vil2 </italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmbp</italic>
Cluster containing invasion and cancer-associated genes. Detailed view of the cluster that contains genes implicated in invasion and other cancer-associated phenotypes, including Cxcl10, Vil2 and Dnmbp.
###end p 55
###begin p 56
###xml 138 144 138 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 146 151 146 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras </italic>
###xml 248 254 248 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 262 267 262 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Dnmbp</italic>
###xml 269 275 269 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 281 287 281 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpv2 </italic>
###xml 429 431 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 446 448 446 448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a</xref>
Of additional interest in relation to the MMP-2-dependent difference in FLS invasion that we have observed, three of these genes - namely Cxcl10, Vil2 and Nras - are known to regulate the synthesis or activation of gelatinases. Increased levels of Cxcl10, Vil2, Dnmbp, Trim16, and Trpv2 in DA were confirmed using quantitative real-time PCR, with most of these genes having a nearly fourfold or greater difference in expression (P < 0.05; Figure 4a).
###end p 56
###begin p 57
###xml 81 85 81 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 150 154 150 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 315 320 315 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esr1 </italic>
###xml 324 329 324 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esr2 </italic>
###xml 350 352 350 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 360 361 360 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink">#</sup>
###xml 361 363 361 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Quantitative real-time PCR. Presented are quantitative real-time PCR analysis of (a) genes upregulated in DA and downregulated in DA.F344(Cia5d), and (b) genes downregulated in DA and upregulated in DA.F344(Cia5d). These include invasion and cancer-associated genes and estrogen-inducible genes. Estrogen receptors Esr1 and Esr2 were also analyzed. *P < 0.05, #P < 0.07.
###end p 57
###begin title 58
Genes downregulated in the highly invasive DA FLSs and upregulated in DA.F344(Cia5d) include tumor suppressor and cell cycle check-point genes
###end title 58
###begin p 59
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Aph1a</italic>
###xml 234 239 234 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brwd3</italic>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b</italic>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gmfg</italic>
###xml 256 259 256 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lox</italic>
###xml 265 273 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plekhg2 </italic>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b </italic>
###xml 348 350 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
The list of genes with reduced expression in DA, as compared with increased expression in DA.F344(Cia5d) congenics, included seven genes that are involved in tumor suppression-like activity and cell cycle check-points, such as Aph1a, Brwd3, Gadd45b, Gmfg, Lox, and Plekhg2 (Table 3). Gadd45b was chosen for quantitative real-time PCR confirmation (P < 0.05; Figure 4b). These observations, combined with the 11 cancer and invasion associated genes upregulated in DA, suggest an invasion-favoring profile similar to that described in cancer cells, characterized by reduced expression cell cycle check-point and tumor suppressor genes combined with increased expression of invasion genes.
###end p 59
###begin title 60
Additional genes with reduced expression in DA FLSs
###end title 60
###begin p 61
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ubxd2</italic>
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fzd4</italic>
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fkbp7</italic>
###xml 34 41 34 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Olfml2b</italic>
###xml 43 51 43 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsdmdc1 </italic>
###xml 88 94 88 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1 </italic>
###xml 184 191 184 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtlf3b </italic>
###xml 313 315 313 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 354 355 354 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 411 419 411 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Olfml2b </italic>
###xml 423 431 423 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gsdmdc1 </italic>
###xml 485 487 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
Additionally, Ubxd2, Fzd4, Fkbp7, Olfml2b, Gsdmdc1 and the transcriptional co-repressor Ncor1 were among the genes downregulated in DA and with increased expression in DA.F344(Cia5d). Gtlf3b (predicted), a gene trap fragment with unknown function, was among the most significantly differentially expressed genes (P = 0.000025; 2.2-fold difference; Table 3). The greater than twofold difference in expression of Olfml2b and Gsdmdc1 was confirmed with quantitative real-time PCR (Figure 4b).
###end p 61
###begin title 62
Increased number of estrogen-inducible and ER signaling regulatory genes among the differentially expressed genes
###end title 62
###begin p 63
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 115 119 115 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 121 127 121 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gins3 </italic>
###xml 152 159 152 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b</italic>
###xml 238 244 238 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stub1 </italic>
###xml 248 253 248 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stip1</italic>
###xml 255 261 255 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1 </italic>
###xml 435 441 435 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 443 447 443 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 449 455 449 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 457 462 457 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gins3</italic>
###xml 468 476 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b </italic>
###xml 530 535 530 535 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a, b</xref>
###xml 546 551 546 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esr1 </italic>
###xml 555 560 555 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esr2 </italic>
###xml 695 697 695 697 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
###xml 746 751 746 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Esr2 </italic>
###xml 830 832 830 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4b</xref>
Nine genes or 13.6% of the 66 differentially expressed genes were either estrogen-inducible genes, such as Cxcl10, Vil2, Trim16, Gins3 (predicted), and Gadd45b, or genes involved in modulating the estrogen receptor (ER) signaling such as Stub1 and Stip1. Ncor1 negatively regulates ER-mediated transcription and its levels were also reduced in DA, further suggesting unopposed ER-mediated transcription. The differential expression of Cxcl10, Vil2, Trim16, Gins3, and Gadd45b was confirmed with quantitative real-time PCR (Figure 4a, b). The ERs Esr1 and Esr2 were not differentially expressed in the microarray analysis, and those results were confirmed with quantitative real-time PCR (Figure 4b). There was a trend toward increased expression Esr2 in DA.F344(Cia5d), but that difference did not reach statistical significance (P = 0.093; Figure 4b). Taken together, this pattern of gene expression suggests that the invasive DA FLSs have an enhanced ER activity regulated at different levels that could include reduced degradation of the ER, reduced inhibition of the ER-mediated transcription, and increased levels of estrogen-inducible genes.
###end p 63
###begin title 64
Five of the differentially expressed genes are located within the Cia5d interval
###end title 64
###begin p 65
###xml 74 80 74 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 96 97 96 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T4">4</xref>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 318 320 318 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 335 337 333 335 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
###xml 366 367 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T5">5</xref>
Five out of the 66 differentially expressed genes were located within the Cia5d interval (Table 4). The number of genes located within the Cia5d interval found to be differentially expressed between DA and DA.F344(Cia5d) FLSs was greater than would be expected by chance (3.3% observed versus 0.8% expected by chance; P = 0.0044 by chi2 with Yates correction; Table 5).
###end p 65
###begin p 66
###xml 68 71 <span type="species:ncbi:10116">rat</span>
Differentially expressed genes located within the Cia5d interval on rat chromosome 10
###end p 66
###begin p 67
###xml 110 111 110 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
A greater than expected number of genes located within the Cia5d interval were differentially expressed in FLSa
###end p 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink">a</sup>
ap-value = 0.00442 (Chi-square with Yates correction).
###end p 68
###begin p 69
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 8 13 8 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpv2</italic>
###xml 19 25 19 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1 </italic>
Trim16, Trpv2, and Ncor1 are closely located on chromosome 10q23, raising the possibility that a polymorphism in a regulatory region or intron in this region, or even in one of these genes, could account for the difference in expression detected between the two strains.
###end p 69
###begin title 70
Discussion
###end title 70
###begin p 71
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 398 407 398 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 542 544 542 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 582 591 582 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
RA histology is typically characterized by pronounced synovial hyperplasia, also called 'pannus'. The RA pannus produces proinflammatory cytokines and proteases, and invades cartilage and bone leading to joint destruction and deformities [4]. The FLS is a key player in RA pannus and joint pathology, and has increased invasive properties, compared with osteoarthritis, even after several passages in vitro [12,27]. Furthermore, the increased invasive properties of RA FLSs have been associated with increased radiographic joint destruction [13], underscoring the relevance of this in vitro phenotype to disease outcome.
###end p 71
###begin p 72
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 185 191 185 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 486 488 486 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 705 707 705 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 742 748 742 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 407 415 <span type="species:ncbi:9606">patients</span>
We recently described the first evidence that the invasive properties of FLSs are genetically regulated [15]. We determined that a gene located within the arthritis severity regulatory Cia5d interval specifically controls the invasive properties of FLSs via the regulation of the production of soluble MT1-MMP and activation of MMP-2 [15]. Levels of active MMP-2 are also increased in the synovial fluid of patients with RA, and correlate with disease severity and radiographic damage [28]. Therefore, understanding the regulation of cell invasion and MMP-2 activation is highly relevant to RA. In addition, several common cancers have increased levels of MMP-2, which correlates with worse prognosis [29-36], suggesting that identifying the Cia5d gene and the pathways controlled by it could potentially generate novel targets relevant to cancer treatment as well.
###end p 72
###begin p 73
###xml 940 949 940 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 1153 1155 1153 1155 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
In the present study we used a novel strategy to identify differences in gene expression that correlate with the invasive properties of FLSs. First, two closely related strains were used. These strains have identical DA genomes, except that DA.F344(Cia5d) congenics have F344 arthritis-resistant alleles in a 37.2 megabase interval on chromosome 10. This strategy minimized noise related to allelic variations at other regions of the genome that are not related to the phenotype of interest. Second, instead of using synovial tissues, which have mixed cellularities that interfere with the interpretation of the results, we generate and used primary FLS cell lines. Third, FLSs from DA and DA.F344(Cia5d) differ in their invasive properties, thus providing a more precise phenotype. Finally, the cells used for RNA extractions were cultured on the same collagen matrix (Matrigel) used in the invasion experiments, hence recreating the same in vitro environment. This latter aspect is critical because extracellular matrix and cell influence processes that are central to cell invasion, such as the expression of adhesion molecules and MMP-2 activation [19], and are required for proper activation of the invasive phenotype, including gene transcription. This strategy led to the identification of new genes involved in FLS invasion.
###end p 73
###begin p 74
###xml 169 171 169 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
A genome-wide analysis of gene expression conducted with RA FLSs suggested two patterns that correlated with increased or reduced inflammation in the tissues of origin [37]. Those RA FLSs were not studied for invasion, and there was no control group without erosive changes for comparison. Furthermore, the RNA was obtained from cells cultured on plastic dishes and not on a collagen matrix such as Matrigel. Therefore, it was not surprising that using different methodologies to address a different question we detected a new FLS invasion signature that is different from the two RA FLS gene expression patterns previously reported.
###end p 74
###begin p 75
###xml 349 351 349 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 646 651 646 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hnrpd</italic>
###xml 654 656 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 673 679 673 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ach1a </italic>
###xml 683 687 683 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gfmg</italic>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 722 729 722 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plekgh2</italic>
###xml 732 734 732 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 754 761 754 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b</italic>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 796 801 796 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Brwd3</italic>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 836 842 836 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ube2d3</italic>
###xml 845 847 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gmfg</italic>
###xml 877 879 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 901 911 901 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lox, Ach1a</italic>
###xml 913 919 913 919 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 921 925 921 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras</italic>
###xml 938 940 938 940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 941 943 941 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 987 992 987 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rpa3 </italic>
###xml 1048 1050 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1092 1097 1092 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Rpa2 </italic>
###xml 1149 1151 1149 1151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 1241 1247 1241 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hnrpd </italic>
###xml 1251 1255 1251 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lsm8</italic>
###xml 1258 1260 1258 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 1299 1301 1299 1301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 1548 1553 1548 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d</italic>
A genome-wide microarray-based gene expression analysis was conducted to identify genes and pathways that are differentially expressed between highly invasive DA and minimally invasive DA.F344(Cia5d) FLSs. The analysis revealed that 66 genes out of the 7,665 genes expressed by FLSs were differentially expressed between DA and DA.F344(Cia5d) FLSs (P < 0.01). Nineteen of the 66 differentially expressed genes (28.7%) had previously been implicated in tumor suppression activity or other cancer cell phenotypes, but had not been implicated in the invasive properties of the FLSs. These cancer-related phenotypes include malignant transformation (Hnrpd) [38], tumor growth (Ach1a and Gfmg) [39,40], oncogene-like activity (Plekgh2) [41], tumor apoptosis (Gadd45b) [42], tumor suppressor activity (Brwd3) [43], cancer cell growth arrest (Ube2d3) [44], contact inhibition (Gmfg) [45], and cell invasion (Lox, Ach1a, Cxcl10, Vil2, and Nras) [46-50]. Genetic variations in DNA synthesis gene Rpa3 have been associated with susceptibility to carcinomas [51], whereas increased cancer expression of Rpa2 is associated with adverse outcome in colon cancer [52]. Some of these genes were found to be expressed in increased levels in certain cancers (Hnrpd and Lsm8) [53,54], including highly invasive types [55]. These observations suggest that FLSs derived from arthritis joints and cancer cells share common processes in the regulation of cell invasion, and that these processes are in part regulated by a gene located within the arthritis severity locus Cia5d.
###end p 75
###begin p 76
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras </italic>
###xml 6 8 6 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 9 11 9 11 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 52 54 52 54 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 61 68 61 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 263 264 263 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 428 434 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 488 490 488 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 491 493 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 559 566 559 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 599 606 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 693 695 693 695 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B61">61</xref>
###xml 739 748 739 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 763 768 <span type="species:ncbi:9606">human</span>
Nras [56,57], Vil2 (encoding the ezrin protein) [49,50], and Cxcl10 [58] - three genes that are upregulated in DA but downregulated in DA.F344(Cia5d) - have also been implicated in the regulation of gelatinases' expression and activation, including MMP-2 (Figure 5). These observations provide a direct link between the invasion and MMP-2 phenotypes that we have been studying and the gene expression signature regulated by the Cia5d locus. Furthermore, studies with RA synovial tissues [59,60] and RA FLSs [60] have also demonstrated increased expression of Cxcl10 both at mRNA and protein levels. Cxcl10 has also been shown to increase the production and activity of gelatinases in RA FLSs [61], underscoring the direct relevance of our in vitro discoveries to human disease.
###end p 76
###begin p 77
###xml 263 269 260 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 271 275 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nras</italic>
###xml 281 286 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
Known interactions between genes differentially expressed in FLSs from DA and DA.F344(Cia5d). Several estrogen (beta-estradiol)-regulated genes, including genes involved in increasing either the expression or activity of matrix metalloproteinase (MMP)-2, such as Cxcl10, Nras, and Vil2 were differentially expressed. Green indicates downregulated in DA.F344(Cia5d) and upregulated in DA. Red indicates upregulated in DA.F344(Cia5d) and downregulated in DA. White indicates that the gene is part of the pathway but was not differentially expressed in fibroblast-like synoviocytes (FLSs) from the two strains. Color intensity correlates with magnitude of the expression difference.
###end p 77
###begin p 78
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B62">62</xref>
###xml 234 236 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 340 347 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 375 377 375 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
In addition to the proinvasive and MMP-2 activating properties associated with Cxcl10 in FLSs, this chemokine can also attract C-X-C chemokine receptor (CXCR)3-expressing inflammatory cells such as memory T cells [62] and mast cells [59] into the joint, further contributing to disease severity. Indeed, recent studies that either targeted Cxcl10 [63] or its receptor CXCR3 [64] significantly ameliorated arthritis in rodents.
###end p 78
###begin p 79
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10 </italic>
###xml 8 10 8 10 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B65">65</xref>
###xml 13 18 13 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2 </italic>
###xml 19 21 19 21 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16 </italic>
###xml 36 38 36 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 145 146 145 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 287 293 287 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cxcl10</italic>
###xml 295 299 295 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vil2</italic>
###xml 301 307 301 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gins3</italic>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gadd45b</italic>
###xml 329 333 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gmfg</italic>
###xml 336 338 336 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 373 378 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stip1</italic>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stub1</italic>
###xml 438 443 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1</italic>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 804 806 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 807 809 807 809 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
###xml 875 884 875 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
###xml 916 918 916 918 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B74">74</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 1016 1018 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B75">75</xref>
###xml 1147 1153 1147 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
Cxcl10 [65], Vil2 [66], and Trim16 [67] - three of the most significantly upregulated genes in DA - are known to be induced by estrogens (Figure 5). A complete analysis of all of the 66 differentially expressed genes revealed that nine of them (13.6%) were either regulated by estrogen (Cxcl10, Vil2, Trim16, Gins3, Gadd45b, and Gmfg) [68] or are involved in ER signaling (Stip1), ER ubiquitination (Stub1), or ER-mediated transcription (Ncor1). These observations suggested that abnormalities in the regulation of ER signaling and ER-mediated transcription could contribute to the invasive properties of DA FLSs. Indeed, estrogens have been shown to increase levels of active MMP-2 in various tissues and cell types [69-71], including breast cancers [72], and estrogen antagonists reversed that effect [71,73]. Estrogens also increase the production of active MMP-2 and the in vitro invasive properties of RA FLSs [74] (Figure 5). Although estrogens are typically thought of as having anti-inflammatory properties [75], our observations suggest an intrinsic dysregulation in ER signaling in DA FLSs. This dysregulation in ER is controlled by the Cia5d gene, and could contribute to increased FLS invasion and cartilage and bone erosive changes.
###end p 79
###begin p 80
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 191 196 191 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1</italic>
###xml 198 204 198 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim41</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtlf3b</italic>
###xml 264 270 264 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpv2 </italic>
###xml 274 280 274 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 428 433 428 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d</italic>
###xml 820 822 820 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B76">76</xref>
###xml 823 825 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B77">77</xref>
###xml 854 859 854 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ncor1</italic>
###xml 953 959 953 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trpv2 </italic>
###xml 1030 1036 1030 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim16</italic>
###xml 1038 1044 1038 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Trim41</italic>
###xml 1050 1056 1050 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gtlf3b</italic>
###xml 1089 1095 1089 1095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
Five of the differentially expressed genes were located within the Cia5d interval, and this number was greater than expected by chance. Three of these were upregulated in DA.F344(Cia5d) FLS (Ncor1, Trim41, and Gtlf3b) and two were downregulated in DA.F344(Cia5d) (Trpv2 and Trim16), raising the possibility that a polymorphism/mutation in one of these genes could explain the arthritis and FLS invasive phenotypes attributed to Cia5d. Specifically, a polymorphism in a regulatory element or intron in one of these genes, or in another gene in the region, could influence transcription, thus explaining differences in levels of mRNA and disease. This has been the case in studies of two other autoimmune or inflammatory diseases in which microarray analysis led to the identification of the disease-causing polymorphism [76,77]. In the present study only Ncor1, a transcriptional repressor regulated by estrogens, appears to be an interesting candidate. Trpv2 is a cation channel ubiquitously expressed, and the other three genes (Trim16, Trim41, and Gtlf3b) have less clear functions. The Cia5d interval contains more than 100 genes, and not all were present in the Illumina microarray. It would be premature to exclude these genes at this point, and additional studies with recombinant subcongenic strains are under way.
###end p 80
###begin title 81
Conclusion
###end title 81
###begin p 82
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d</italic>
###xml 265 271 265 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cia5d </italic>
We have identified a novel invasion-associated gene expression signature and evidence suggesting a dysregulation in ER signaling in arthritis FLSs, which are regulated by the arthritis severity locus Cia5d. It is anticipated that the specific identification of the Cia5d gene, and the continued characterization of processes regulated by this gene, will generate new targets for therapeutic intervention aimed at reducing cartilage and bone destruction, and new prognostic markers for RA. The parallels between our findings in FLSs and observations from cancer studies suggest that the Cia5d gene might be important for cancer biology as well.
###end p 82
###begin title 83
Abbreviations
###end title 83
###begin p 84
CXCR: C-X-C chemokine receptor; DMEM: Dulbecco's modified Eagle's medium; ER: estrogen receptor; FLS: fibroblast-like synoviocyte; GAPDH: glyceraldehyde-3-phosphate dehydrogenase; MMP: matrix metalloproteinase; MT1: membrane-type 1; PCR: polymerase chain reaction; RA: rheumatoid arthritis.
###end p 84
###begin title 85
Competing interests
###end title 85
###begin p 86
The authors declare that they have no competing interests.
###end p 86
###begin title 87
Authors' contributions
###end title 87
###begin p 88
All authors made substantial contributions to this study. TL generated the FLS cell lines and worked on the gene expression analyses. MB conducted the cellular and molecular biology experiments. WL worked on the gene expression statistical analysis. PSG designed the study and conducted the microarray gene expression analysis and pathway discovery, and wrote the manuscript. All authors read the manuscript critically, suggested modifications, and approved the final version.
###end p 88
###begin title 89
Ackowledgments
###end title 89
###begin p 90
This study was funded by National Institutes of Health grants R01-AR46213, R01-AR052439 (NIAMS), and R01-AI54348 (NIAID) to Dr P Gulko. The authors want to thank Franak Batliwalla and Aarti Damle, members of the Feinstein Institute's microarray core facility, for their assistance.
###end p 90
###begin article-title 91
Genetics of rheumatoid arthritis
###end article-title 91
###begin article-title 92
###xml 32 37 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties
###end article-title 92
###begin article-title 93
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline
###end article-title 93
###begin article-title 94
Rheumatoid arthritis
###end article-title 94
###begin article-title 95
Cadherin-11 in synovial lining formation and pathology in arthritis
###end article-title 95
###begin article-title 96
Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation
###end article-title 96
###begin article-title 97
Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia
###end article-title 97
###begin article-title 98
###xml 72 87 <span type="species:ncbi:10090">transgenic mice</span>
Anti-TNF-alpha antibody allows healing of joint damage in polyarthritic transgenic mice
###end article-title 98
###begin article-title 99
Exacerbation of acute inflammatory arthritis by the colony-stimulating factors CSF-1 and granulocyte macrophage (GM)-CSF: evidence of macrophage infiltration and local proliferation
###end article-title 99
###begin article-title 100
NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint
###end article-title 100
###begin article-title 101
###xml 48 55 <span type="species:ncbi:9986">rabbits</span>
Decreased angiogenesis and arthritic disease in rabbits treated with an alphavbeta3 antagonist
###end article-title 101
###begin article-title 102
###xml 24 32 <span type="species:ncbi:9606">patients</span>
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice
###end article-title 102
###begin article-title 103
###xml 62 69 <span type="species:ncbi:9606">patient</span>
###xml 134 142 <span type="species:ncbi:9606">patients</span>
Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis
###end article-title 103
###begin article-title 104
The non-MHC quantitative trait locus Cia5 contains three major arthritis genes that differentially regulate disease severity, pannus formation, and joint damage in collagen- and pristane-induced arthritis
###end article-title 104
###begin article-title 105
The arthritis severity locus Cia5d is a novel genetic regulator of the invasive properties of synovial fibroblasts
###end article-title 105
###begin article-title 106
###xml 30 34 <span type="species:ncbi:10116">rats</span>
Pristane-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by both major histocompatibility complex and non-major histocompatibility complex genes
###end article-title 106
###begin article-title 107
###xml 155 159 <span type="species:ncbi:10116">rats</span>
Identification of a new non-major histocompatibility complex genetic locus on chromosome 2 that controls disease severity in collagen-induced arthritis in rats
###end article-title 107
###begin article-title 108
###xml 84 88 <span type="species:ncbi:10116">rats</span>
A genome scan localizes five non-MHC loci controlling collagen-induced arthritis in rats
###end article-title 108
###begin article-title 109
###xml 41 46 <span type="species:ncbi:9606">human</span>
Matrix metalloproteinase-2 activation in human hepatic fibrosis regulation by cell-matrix interactions
###end article-title 109
###begin article-title 110
Peripheral blood gene expression profiling in rheumatoid arthritis
###end article-title 110
###begin article-title 111
Zipf's law in importance of genes for cancer classification using microarray data
###end article-title 111
###begin article-title 112
R statistical package
###end article-title 112
###begin article-title 113
Cluster analysis and display of genome-wide expression patterns
###end article-title 113
###begin article-title 114
Treeview
###end article-title 114
###begin article-title 115
###xml 84 98 84 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-&#916;&#916;CT </sup>
Analysis of relative gene expression data using real-time quantitative PCR and the 2-DeltaDeltaCT method
###end article-title 115
###begin article-title 116
Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture: primary culture cells markedly differ from fourth-passage cells
###end article-title 116
###begin article-title 117
Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10
###end article-title 117
###begin article-title 118
###xml 87 95 <span type="species:ncbi:9606">patients</span>
Active synovial matrix metalloproteinase-2 is associated with radiographic erosions in patients with early synovitis
###end article-title 118
###begin article-title 119
###xml 73 78 <span type="species:ncbi:9606">human</span>
Association of MMP-2 activation potential with metastatic progression in human breast cancer cell lines independent of MMP-2 production
###end article-title 119
###begin article-title 120
###xml 47 56 47 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro </italic>
Differential influence of antiestrogens on the in vitro release of gelatinases (type IV collagenases) by invasive and non-invasive breast cancer cells
###end article-title 120
###begin article-title 121
Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy
###end article-title 121
###begin article-title 122
Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection
###end article-title 122
###begin article-title 123
Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma
###end article-title 123
###begin article-title 124
The role of matrix metalloproteinases in glioma invasion
###end article-title 124
###begin article-title 125
Matrix metalloproteinases and metastatic cancer
###end article-title 125
###begin article-title 126
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion
###end article-title 126
###begin article-title 127
###xml 42 50 <span type="species:ncbi:9606">patients</span>
Fibroblast-like synoviocytes derived from patients with rheumatoid arthritis show the imprint of synovial tissue heterogeneity: evidence of a link between an increased myofibroblast-like phenotype and high-inflammation synovitis
###end article-title 127
###begin article-title 128
###xml 82 97 <span type="species:ncbi:10090">transgenic mice</span>
A new player in oncogenesis: AUF1/hnRNPD overexpression leads to tumorigenesis in transgenic mice
###end article-title 128
###begin article-title 129
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Transcriptional profiling of the transition from normal intestinal epithelia to adenomas and carcinomas in the APCMin/+ mouse
###end article-title 129
###begin article-title 130
Glia maturation factor beta regulates the growth of N18 neuroblastoma cells
###end article-title 130
###begin article-title 131
Activation of clg, a novel dbl family guanine nucleotide exchange factor gene, by proviral insertion at evi24, a common integration site in B cell and myeloid leukemias
###end article-title 131
###begin article-title 132
###xml 68 73 <span type="species:ncbi:9606">human</span>
The induction of growth arrest DNA damage-inducible gene 45 beta in human hepatoma cell lines by S-adenosylmethionine
###end article-title 132
###begin article-title 133
Identification of JAK/STAT signalling components by genome-wide RNA interference
###end article-title 133
###begin article-title 134
###xml 101 106 <span type="species:ncbi:9606">human</span>
RNAi screen identifies UBE2D3 as a mediator of all-trans retinoic acid-induced cell growth arrest in human acute promyelocytic NB4 cells
###end article-title 134
###begin article-title 135
Glia maturation factor promotes contact inhibition in cancer cells
###end article-title 135
###begin article-title 136
A molecular role for lysyl oxidase in breast cancer invasion
###end article-title 136
###begin article-title 137
Identification of MMP-1 as a putative breast cancer predictive marker by global gene expression analysis
###end article-title 137
###begin article-title 138
###xml 47 52 <span type="species:ncbi:9606">human</span>
CXCL10 promotes invasion-related properties in human colorectal carcinoma cells
###end article-title 138
###begin article-title 139
Derivation and characterization of a Wilms' tumour cell line, WiT 49
###end article-title 139
###begin article-title 140
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
Podocalyxin increases the aggressive phenotype of breast and prostate cancer cells in vitro through its interaction with ezrin
###end article-title 140
###begin article-title 141
Polymorphism discovery in 62 DNA repair genes and haplotype associations with risks for lung and head and neck cancers
###end article-title 141
###begin article-title 142
Replication protein A is an independent prognostic indicator with potential therapeutic implications in colon cancer
###end article-title 142
###begin article-title 143
###xml 90 95 <span type="species:ncbi:9606">human</span>
Identification of differentially expressed genes by serial analysis of gene expression in human prostate cancer
###end article-title 143
###begin article-title 144
Identification of RASSF1A modulated genes in nasopharyngeal carcinoma
###end article-title 144
###begin article-title 145
The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types
###end article-title 145
###begin article-title 146
###xml 75 80 <span type="species:ncbi:9606">human</span>
Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors
###end article-title 146
###begin article-title 147
Ras pathway is required for the activation of MMP-2 secretion and for the invasion of src-transformed 3Y1
###end article-title 147
###begin article-title 148
CXCR3-binding chemokines in multiple myeloma
###end article-title 148
###begin article-title 149
###xml 125 133 <span type="species:ncbi:9606">patients</span>
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis
###end article-title 149
###begin article-title 150
###xml 74 82 <span type="species:ncbi:9606">patients</span>
The production of CXCR3-agonistic chemokines by synovial fibroblasts from patients with rheumatoid arthritis
###end article-title 150
###begin article-title 151
###xml 163 171 <span type="species:ncbi:9606">patients</span>
CC and CXC chemokine receptors mediate migration, proliferation, and matrix metalloproteinase production by fibroblast-like synoviocytes from rheumatoid arthritis patients
###end article-title 151
###begin article-title 152
###xml 86 94 <span type="species:ncbi:9606">patients</span>
CCR3, CCR5, CCR8 and CXCR3 expression in memory T helper cells from allergic rhinitis patients, asymptomatically sensitized and healthy individuals
###end article-title 152
###begin article-title 153
Targeting the function of IFN-gamma-inducible protein 10 suppresses ongoing adjuvant arthritis
###end article-title 153
###begin article-title 154
Blockade of chemokine receptor CXCR3 inhibits T cell recruitment to inflamed joints and decreases the severity of adjuvant arthritis
###end article-title 154
###begin article-title 155
###xml 81 86 <span type="species:ncbi:9606">human</span>
Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone
###end article-title 155
###begin article-title 156
Reciprocal regulation by estradiol 17-beta of ezrin and cadherin-catenin complexes in pituitary GH3 cells
###end article-title 156
###begin article-title 157
The novel estrogen-responsive B-box protein (EBBP) gene is tamoxifen-regulated in cells expressing an estrogen receptor DNA-binding domain mutant
###end article-title 157
###begin article-title 158
Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes
###end article-title 158
###begin article-title 159
###xml 112 115 <span type="species:ncbi:10116">rat</span>
Differential effects of estrogen and raloxifene on messenger RNA and matrix metalloproteinase 2 activity in the rat uterus
###end article-title 159
###begin article-title 160
Activation of matrix metalloproteinase-2 and -9 by 2- and 4-hydroxyestradiol
###end article-title 160
###begin article-title 161
###xml 70 75 <span type="species:ncbi:9606">human</span>
17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells
###end article-title 161
###begin article-title 162
###xml 79 84 <span type="species:ncbi:9606">human</span>
Ethanol stimulates the secretion of matrix metalloproteinases 2 and 9 in MCF-7 human breast cancer cells
###end article-title 162
###begin article-title 163
###xml 112 117 <span type="species:ncbi:9606">human</span>
Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells
###end article-title 163
###begin article-title 164
###xml 83 91 83 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 40 45 <span type="species:ncbi:9606">human</span>
Estrogen and progesterone regulation of human fibroblast-like synoviocyte function in vitro: implications in rheumatoid arthritis
###end article-title 164
###begin article-title 165
The complex role of estrogens in inflammation
###end article-title 165
###begin article-title 166
Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus
###end article-title 166
###begin article-title 167
Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma
###end article-title 167

